冠脉CT血管成像对健康生活方式与预防治疗的影响:SCOT-HEART 2嵌套子研究
该研究为SCOT-HEART 2随机临床试验的嵌套子研究,纳入400名40-70岁无心血管病但至少有一项危险因素的无症状个体,比较冠脉CT血管成像与指南导向的心血管风险评分对健康生活方式、预防治疗接受度及危险因素改善的影响。结果显示,CT组6个月时达到饮食、BMI、吸烟和运动复合终点的比例更高(17% vs 6%),推荐预防治疗的比例更低但接受度更高,抗血小板治疗使用更多,降脂治疗使用相似,危险因素和10年心血管风险有小幅改善。
要点
- 冠脉CT血管成像较风险评分小幅改善健康生活方式依从性(17% vs 6%)。
- CT组推荐预防治疗比例更低(51% vs 75%),但接受度更高(77% vs 46%)。
- CT组抗血小板治疗使用率更高(40% vs 0.5%),降脂治疗使用相似。
核心结论
- 与心血管风险评分相比,冠脉CT血管成像与健康生活方式行为、推荐预防治疗接受度和危险因素改善的小幅提升相关。
- 该策略能否减少冠状动脉事件尚待确定。
研究设计与样本
- SCOT-HEART 2随机临床试验的嵌套子研究,2020年9月至2024年8月在苏格兰基层医疗筛查中开展。
- 纳入400名40-70岁无已知心血管病且至少有一项心血管危险因素的无症状个体,随机分入心血管风险评分组(195人)或冠脉CT血管成像组(205人)。
主要发现
- 6个月时CT组达到饮食、BMI、吸烟和运动复合终点的比例为17%(33/194),风险评分组为6%(10/177),OR 3.42(95%CI 1.63-6.94),P<.001。
- CT组推荐预防治疗的比例为51%(105/205),低于风险评分组的75%(147/195),P<.001;但接受推荐的比例更高(77% [81/105] vs 46% [68/147],P<.001)。
- 降脂治疗使用率CT组44%(90/205) vs 风险评分组35%(69/195),OR 1.43(95%CI 0.96-2.15),P=.08。
- 抗血小板治疗使用率CT组40%(83/205) vs 风险评分组0.5%(1/195),P<.001。
- 随机分入冠脉CT血管成像组的参与者危险因素和10年心血管风险有小幅增量改善,主要由CT定义有冠状动脉粥样硬化者驱动。
关键数值与推荐
- 所有参与者接受生活方式建议,若10年心血管风险≥10%则额外推荐中等强度他汀治疗;若CT血管成像发现冠状动脉粥样硬化则推荐联合抗血小板和至少中等强度他汀治疗。
- 主要复合终点为6个月时符合NICE关于饮食、BMI、吸烟和体育锻炼的建议。
临床怎么用
- 在无症状但存在心血管危险因素的人群中,冠脉CT血管成像可小幅促进健康生活方式依从性并提高预防治疗接受度。
- CT发现冠状动脉粥样硬化时推荐联合抗血小板和至少中等强度他汀治疗,可能增加抗血小板治疗使用。
- 该策略对临床事件的影响尚未明确,需等待后续结局数据。
局限性
- 原文未报告
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Healthy lifestyles and uptake of primary preventive therapies for cardiovascular disease remain poor. OBJECTIVE: To determine the impact of coronary computed tomography (CT) angiography on healthy lifestyle behaviors, acceptance of recommended treatments, and modification of risk factors as compared with guideline-directed cardiovascular risk scoring. DESIGN, SETTING, AND PARTICIPANTS: This was a nested substudy conducted from September 2020 to August 2024 of a randomized clinical trial where participants underwent cardiovascular risk scoring or coronary CT angiography. Primary care-based screening took place in Scotland. Included in the analysis were asymptomatic individuals aged 40 to 70 years without known cardiovascular disease and with at least 1 cardiovascular risk factor. Study data were analyzed from August to September 2024. INTERVENTIONS: All participants received lifestyle advice with additional recommendations for moderate-intensity statin therapy if the 10-year cardiovascular risk was greater than or equal to 10% or combined antiplatelet and at least moderate-intensity statin therapies if coronary atherosclerosis was identified on CT angiography. MAIN OUTCOMES AND MEASURES: The composite primary outcome was compliance with the National Institute for Health and Care Excellence recommendations for diet, body mass index, smoking, and physical exercise at 6 months. RESULTS: Between September 2020 and January 2024, 400 participants were enrolled (median [IQR] age, 62 [56-65] years; 198 female [49.5%]; median [IQR] 10-year cardiovascular risk, 14% [9%-19%]) with 195 randomized to cardiovascular risk scoring and 205 to coronary CT angiography. At 6 months, those who underwent CT angiography were more likely to meet the primary composite end point (17% [33 of 194 participants] vs 6% [10 of 177 participants]; odds ratio, 3.42; 95% CI, 1.63-6.94; P < .001). Compared with cardiovascular risk scoring, fewer participants were recommended preventive therapy after CT angiography (51% [105 of 205 participants] vs 75% [147 of 195 participants]; P < .001), but acceptance of recommendations was higher (77% [81 of 105 participants] vs 46% [68 of 147 participants]; P < .001). This resulted in similar use of lipid-lowering therapy (44% [90 of 205 participants] vs 35% [69 of 195 participants]; OR, 1.43; 95% CI, 0.96-2.15; P = .08) and greater use of antiplatelet therapy in those randomized to CT angiography (40% [83 of 205 participants] vs 0.5% [1 of 195 participants]; P < .001). Participants randomized to coronary CT angiography had small incremental improvements in risk factors and 10-year cardiovascular risk, largely driven by those with CT-defined coronary atheroma. CONCLUSIONS AND RELEVANCE: Results of this cohort study reveal that compared with cardiovascular risk scoring, coronary CT angiography was associated with modest improvements in healthier lifestyle behaviors, acceptance of recommended preventive therapy, and risk factor modification. Whether this strategy reduces coronary events remains to be established.
引用
- McDermott M, Khaing PH, Meah MN, et al. CT Angiography, Healthy Lifestyle Behaviors, and Preventive Therapy: A Nested Substudy of the SCOT-HEART 2 Randomized Clinical Trial. JAMA Cardiol. 2025. PMID: 40531507. doi:10.1001/jamacardio.2025.1763
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。